- QMRO Home
- William Harvey Research Institute
- Centre for Clinical Pharmacology
- CLOFARABINE IN COMBINATION WITH HIGH-DOSE CYTARABINE AND LIPOSOMAL DAUNORUBICIN IN PEDIATRIC AML: RESULTS OF A PHASE 1 COMBINATION STUDY BY THE ITCC CONSORTIUM
Browse
Administrators only